FLI1 and invasive breast carcinoma: To address these objectives, we employed a comprehensive approach integrating immunohistochemical analysis of FLI1 expression in a well-annotated cohort of invasive breast carcinoma cases, correlation with clinicopathological parameters including histological grade and survival outcomes, and profiling of immune and stromal components within the tumor microenvironment.